Develop and size use cases for seasonal influenza vaccines
MMGH is supporting the US CDC and WHO to validate preliminary use cases and country archetypes previously developed for seasonal influenza vaccines. MMGH is conducting staekholder surveys, interviews and workshops with global influenza experts to validate the use cases and country archetypes for seasonal influenza vaccines developed in the earlier project. These activities are also supporting the development of an analytical framework that is applicable to any influenza vaccine profile (e.g., next-generation and universal influenza vaccines). The project will help to support the full value of seasonal influenza vaccine assessment, including key market dynamics analayses and roadmaps and action plans for current and future seasonal influenza vaccine use.
To enable countries, donor agencies, development partners and manufacturers to make informed decisions on the implementation of current, and development of future seasonal influenza vaccines based on a deep understanding of the use cases and global demand for these vaccines, and potential implementation strategies to reach target populations.
The outputs will help inform WHO’s Full Value Assessment for Improved Influenza Vaccines, as well as key market dynamics assessments, through an improved understanding of the ways in which seasonal influenza vaccines are delivered and administered in different geographic settings.